rsID,Risk_allele,Freq,OR(95%CI),P,Subtype
rs6903608,C,0.42,1.64(1.51-1.78),7.00E-31,All Subtypes combined
rs204999,G,0.23,0.77(0.7-0.85),2.00E-07,All Subtypes combined
rs2734986,C,0.21,1.32(1.19-1.47),3.00E-07,All Subtypes combined
rs6904029,A,0.27,0.86(0.79-0.94),1.00E-03,All Subtypes combined
rs20541,A,0.24,1.37(1.25-1.51),1.00E-10,All Subtypes combined
rs2019960,C,0.27,1.3(1.18-1.43),7.00E-08,All Subtypes combined
rs2069757,A,0.11,1.59(1.39-1.82),2.00E-11,All Subtypes combined
rs3806624,G,0.5,1.17(1.08-1.27),2.26E-04,All Subtypes combined
rs9402684,T,0.52,1.19(1.09-1.29),5.40E-05,All Subtypes combined
rs13034020,G,0.18,1.28(1.16-1.43),3.20E-06,All Subtypes combined
rs444929,C,0.24,1.26(1.14-1.39),3.10E-06,All Subtypes combined
rs6903608,C,0.42,1.69(1.55-1.84),3.00E-32,classical HL
rs204999,G,0.24,0.78(0.7-0.86),7.00E-07,classical HL
rs2734986,C,0.22,1.37(1.23-1.53),2.00E-08,classical HL
rs6904029,A,0.27,0.85(0.77-0.93),5.00E-04,classical HL
rs20541,A,0.24,1.39(1.26-1.53),9.00E-11,classical HL
rs2019960,C,0.26,1.27(1.16-1.4),1.00E-06,classical HL
rs2069757,A,0.11,1.66(1.44-1.9),1.00E-12,classical HL
rs3806624,G,0.5,1.17(1.07-1.27),4.40E-04,classical HL
rs9402684,T,0.52,1.2(1.1-1.3),5.10E-05,classical HL
rs13034020,G,0.18,1.27(1.14-1.42),1.20E-05,classical HL
rs444929,C,0.24,1.27(1.15-1.41),3.20E-06,classical HL
rs204999,G,0.21,0.67(0.59-0.76),1.00E-09,nodular sclerosis HL
rs2734986,C,0.19,1.23(1.07-1.42),4.00E-03,nodular sclerosis HL
rs6904029,A,0.29,0.88(0.78-0.98),3.00E-02,nodular sclerosis HL
rs20541,A,0.26,1.48(1.31-1.68),3.00E-10,nodular sclerosis HL
rs2019960,C,0.27,1.29(1.15-1.46),4.00E-05,nodular sclerosis HL
rs2069757,A,0.11,1.66(1.4-1.98),7.00E-09,nodular sclerosis HL
rs3806624,G,0.51,1.22(1.09-1.35),3.35E-04,nodular sclerosis HL
rs9402684,T,0.52,1.2(1.08-1.33),9.40E-04,nodular sclerosis HL
rs13034020,G,0.18,1.26(1.11-1.45),6.30E-04,nodular sclerosis HL
rs444929,C,0.25,1.33(1.18-1.51),7.80E-06,nodular sclerosis HL
rs6903608,C,0.32,1.14(0.94-1.39),2.00E-01,mixed cellularity HL
rs204999,G,0.31,1.07(0.87-1.32),5.00E-01,mixed cellularity HL
rs2734986,C,0.3,2.01(1.59-2.54),5.00E-09,mixed cellularity HL
rs6904029,A,0.22,0.63(0.51-0.79),4.00E-05,mixed cellularity HL
rs20541,A,0.21,1.21(0.97-1.51),1.00E-01,mixed cellularity HL
rs2019960,C,0.24,1.21(0.98-1.51),8.00E-02,mixed cellularity HL
rs2069757,A,0.1,1.49(1.08-2.04),1.00E-02,mixed cellularity HL
rs3806624,G,0.5,1.15(0.95-1.4),0.144319,mixed cellularity HL
rs9402684,T,0.51,1.23(1.01-1.49),0.035922,mixed cellularity HL
rs13034020,G,0.17,1.08(0.84-1.38),5.40E-01,mixed cellularity HL
rs444929,C,0.2,1.05(0.83-1.34),6.80E-01,mixed cellularity HL
rs6903608,C,0.46,2.03(1.81-2.28),7.00E-33,EBV negative HL
rs204999,G,0.2,0.64(0.55-0.73),2.00E-10,EBV negative HL
rs2734986,C,0.17,0.94(0.8-1.1),4.00E-01,EBV negative HL
rs6904029,A,0.31,1.04(0.92-1.18),5.00E-01,EBV negative HL
rs20541,A,0.26,1.49(1.3-1.69),3.00E-09,EBV negative HL
rs2019960,C,0.28,1.42(1.25-1.61),5.00E-08,EBV negative HL
rs2069757,A,0.12,1.75(1.47-2.1),8.00E-10,EBV negative HL
rs3806624,G,0.49,1.07(0.96-1.2),0.24102,EBV negative HL
rs9402684,T,0.52,1.18(1.06-1.33),4.04E-03,EBV negative HL
rs13034020,G,0.19,1.26(1.09-1.46),1.40E-03,EBV negative HL
rs444929,C,0.25,1.28(1.12-1.47),2.60E-04,EBV negative HL
rs6903608,C,0.27,0.96(0.79-1.17),7.00E-01,EBV positive HL
rs204999,G,0.33,1.16(0.96-1.4),1.00E-01,EBV positive HL
rs2734986,C,0.34,2.2(1.78-2.71),1.00E-13,EBV positive HL
rs6904029,A,0.17,0.47(0.37-0.59),4.00E-10,EBV positive HL
rs20541,A,0.19,1.05(0.84-1.31),7.00E-01,EBV positive HL
rs2019960,C,0.26,1.22(1-1.5),5.00E-02,EBV positive HL
rs2069757,A,0.08,1.13(0.81-1.57),5.00E-01,EBV positive HL
rs3806624,G,0.51,1.17(0.98-1.4),0.084495,EBV positive HL
rs9402684,T,0.51,1.19(1-1.43),5.39E-02,EBV positive HL
rs13034020,G,0.16,1.03(0.81-1.31),8.30E-01,EBV positive HL
rs444929,C,0.21,1(0.8-1.25),1.00E+00,EBV positive HL
rs6903608,C,0.47,1.9(1.69-2.14),6.00E-27,nodular sclerosis HL in 15-35 year olds
rs204999,G,0.19,0.61(0.53-0.71),6.00E-11,nodular sclerosis HL in 15-35 year olds
rs2734986,C,0.18,1.18(1.01-1.38),4.00E-02,nodular sclerosis HL in 15-35 year olds
rs6904029,A,0.3,0.93(0.82-1.06),3.00E-01,nodular sclerosis HL in 15-35 year olds
rs20541,A,0.27,1.5(1.31-1.71),2.00E-09,nodular sclerosis HL in 15-35 year olds
rs2019960,C,0.29,1.42(1.25-1.62),1.00E-07,nodular sclerosis HL in 15-35 year olds
rs2069757,A,0.12,1.84(1.53-2.21),5.00E-11,nodular sclerosis HL in 15-35 year olds
rs3806624,G,0.52,1.26(1.12-1.42),1.02E-04,nodular sclerosis HL in 15-35 year olds
rs9402684,T,0.53,1.19(1.06-1.33),0.004102,nodular sclerosis HL in 15-35 year olds
rs13034020,G,0.19,1.29(1.11-1.49),6.80E-04,nodular sclerosis HL in 15-35 year olds
rs444929,C,0.27,1.38(1.2-1.58),3.60E-06,nodular sclerosis HL in 15-35 year olds